510(k) Report

510(k) · Cleared

Cleared

Euroimmun Anti-LKM-1 Elisa (LGG)

K112223510(k) TraditionalCleared Sep 11, 2012406-day reviewClass II21 CFR 866.5660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Euroimmun US · NBS Autoantibodies, Lkm-1 (Liver/Kidney Microsome, Type 1)

Cleared on Sep 11, 2012 as substantially equivalent to K000535 (Inova Diagnostics, Inc., 2000) after a 406-day review. Its family tree reaches back 1 generation to 2000.

Decided
Sep 11, 2012
Review
406 days
Class
Class II
Product code
NBS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K000535 (2000). No later device cites it as a predicate yet.

K000535 · Quanta Lite LKM-1 Elisa · Inova Diagnostics, Inc. · 200020002002200420062008201020122014
K000535 · Quanta Lite LKM-1 Elisa · Inova Diagnostics, Inc. · 20000
  1. Root · 1 generation backK000535 Quanta Lite LKM-1 ElisaInova Diagnostics, Inc. · 2000
  2. This deviceK112223 Euroimmun Anti-LKM-1 Elisa (LGG)Euroimmun US · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K000535Quanta Lite LKM-1 ElisaInova Diagnostics, Inc.2000—
0 (this device)K112223Euroimmun Anti-LKM-1 Elisa (LGG)Euroimmun US2012—
FIG. 1 — Lineage of K112223, 2000–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000535Quanta Lite LKM-1 Elisa
Summary page 2
…333X J. Substantial Equivalence Information. 1. Predicate device name (s): [nova Quanta Lite LKMV-1 ELISA 2. Predicate 510(k) number(s): K000535 3. Comparison with Predicate: Similarities Item New Device…
Inova Diagnostics, Inc.2000—

Also cleared against K000535: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K000535.

How does its category compare?

All NBS devices

NBS Autoantibodies, Lkm-1 (Liver/Kidney Microsome, Type 1): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · NBS

1in 2017

2012: 12017: 1
2007high 1 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBS

Too few NBS 510(k)s in any year since 2007 to give a median.

Recalls per year · NBS

No recall names NBS since 2007.

Adverse event reports per year · NBS

No MAUDE report names NBS since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20121—00
20130—00
20140—00
20150—00
20160—00
20171—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The EUROIMMUN Anti-LKM-1 ELISA (IgG) test kit is intended for the qualitative detection of IgG class autoantibodies against LKM-1 (cytochrome P450 1106 of liver-kidney-microsomes) in human serum and plasma. It is used as an aid in the diagnosis of autoimmune hepatitis, type 2, in conjunction with other laboratory and clinical findings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112223: Euroimmun Anti-LKM-1 Elisa (LGG).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K112223

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026